Related references
Note: Only part of the references are listed.Longitudinal DAT changes measured with [18F]FE-PE2I PET in patients with Parkinson?s disease; a validation study
V. S. Kerstens et al.
NEUROIMAGE-CLINICAL (2023)
Longitudinal Positron Emission Tomography Imaging of Presynaptic Terminals in Early Parkinson's Disease
Aline Delva et al.
MOVEMENT DISORDERS (2022)
[18F]FE-PE2I PET is a feasible alternative to [123I]FP-CIT SPECT for dopamine transporter imaging in clinically uncertain parkinsonism
Lisbeth Marner et al.
EJNMMI RESEARCH (2022)
EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0
Silvia Morbelli et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)
Reliability of dopamine transporter PET measurements with [18F]FE-PE2I in patients with Parkinson's disease
Vera S. Kerstens et al.
EJNMMI RESEARCH (2020)
Dopamine transporter imaging with [18F]FE-PE2I PET and [123I]FP-CIT SPECTa clinical comparison
Susanna Jakobson Mo et al.
EJNMMI RESEARCH (2018)
Clinical practice guidelines for management of depression in elderly
Ajit Avasthi et al.
INDIAN JOURNAL OF PSYCHIATRY (2018)
Recognition and management of antidepressant discontinuation syndrome
Venkat Bhat et al.
JOURNAL OF PSYCHIATRY & NEUROSCIENCE (2017)
Reproducibility of PET measurement for presynaptic dopaminergic functions using L-[β-11C]DOPA and [18F]FE-PE2I in humans
Masayuki Suzuki et al.
NUCLEAR MEDICINE COMMUNICATIONS (2014)
Blockade of the high-affinity noradrenaline transporter (NET) by the selective 5-HT reuptake inhibitor escitalopram: an in vivo microdialysis study in mice
Hai T. Nguyen et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Serotonin Transporters in Dopamine Transporter Imaging: A Head-to-Head Comparison of Dopamine Transporter SPECT Radioligands I-123-FP-CIT and I-123-PE2I
Morten Ziebell et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
In Vitro Autoradiography and In Vivo Evaluation in Cynomolgus Monkey of [18F]FE-PE2I, a New Dopamine Transporter PET Radioligand
Andrea Varrone et al.
SYNAPSE (2009)
Clinical pharmacokinetics of sertraline
CL DeVane et al.
CLINICAL PHARMACOKINETICS (2002)